Charting Mead Johnson Nutrition's Latest Earnings Release
Mead Johnson Nutrition (NYS: MJN) reported earnings on Oct. 25. Here are the numbers you need to know.
The 10-second takeaway
For the quarter ended Sep. 30 (Q3), Mead Johnson Nutrition missed estimates on revenues and met expectations on earnings per share.
Compared to the prior-year quarter, revenue dropped slightly and GAAP earnings per share shrank.
Margins dropped across the board.
Mead Johnson Nutrition reported revenue of $921.3 million. The 12 analysts polled by S&P Capital IQ looked for revenue of $976.9 million on the same basis. GAAP reported sales were 1.3% lower than the prior-year quarter's $933.9 million.
Source: S&P Capital IQ. Quarterly periods. Dollar amounts in millions. Non-GAAP figures may vary to maintain comparability with estimates.
EPS came in at $0.71. The 15 earnings estimates compiled by S&P Capital IQ anticipated $0.72 per share. GAAP EPS of $0.69 for Q3 were 1.4% lower than the prior-year quarter's $0.70 per share.
Source: S&P Capital IQ. Quarterly periods. Non-GAAP figures may vary to maintain comparability with estimates.
For the quarter, gross margin was 61.2%, 40 basis points worse than the prior-year quarter. Operating margin was 20.9%, 210 basis points worse than the prior-year quarter. Net margin was 15.2%, 30 basis points worse than the prior-year quarter.
Next quarter's average estimate for revenue is $987.5 million. On the bottom line, the average EPS estimate is $0.72.
Next year's average estimate for revenue is $3.97 billion. The average EPS estimate is $3.10.
The stock has a three-star rating (out of five) at Motley Fool CAPS, with 77 members out of 91 rating the stock outperform, and 14 members rating it underperform. Among 27 CAPS All-Star picks (recommendations by the highest-ranked CAPS members), 21 give Mead Johnson Nutrition a green thumbs-up, and six give it a red thumbs-down.
Of Wall Street recommendations tracked by S&P Capital IQ, the average opinion on Mead Johnson Nutrition is outperform, with an average price target of $80.36.
- Add Mead Johnson Nutrition to My Watchlist.
The article Charting Mead Johnson Nutrition's Latest Earnings Release originally appeared on Fool.com.Seth Jayson had no position in any company mentioned here at the time of publication. You can view his stock holdings here. He is co-advisor ofMotley Fool Hidden Gems, which provides new small-cap ideas every month, backed by a real-money portfolio. The Motley Fool has no positions in the stocks mentioned above. Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.